When Biology Outpaces Culture: Health Marketing in an Age of Breakthroughs

"Stigma thrives in silence."

I said those words recently during a conversation about GLP-1s. They seemed to resonate. But afterwards, I couldn't shake the feeling that I had stopped one thought too soon.

Silence isn't always the problem.

Sometimes silence is what happens when our understanding of the world changes before our language does.

Science can create a new possibility almost overnight. Culture takes longer. Not because people resist innovation. But because scientific breakthroughs arrive in the language of science, while our lives are lived in the language of culture.

Science speaks through clinical trials, mechanisms of action, endpoints and confidence intervals. All essential. But none of us experiences health as a clinical endpoint. We experience it through our bodies, our relationships, our identities—and through the stories our cultures have taught us about what health, illness, and recovery are supposed to mean.

Long before we understand biology, we inherit explanations about what causes illness, what recovery should look like, what strength looks like, and what suffering means. We inherit them long before we ever have the language to question them. We repeat those meanings so early and so often that eventually they stop feeling like stories at all. They simply become the way the world is.

Which is why scientific breakthroughs never arrive in an empty culture. They arrive in cultures already organised around inherited ways of making sense of the world.
Nonetheless, culture does not compete with science. It translates scientific possibility into shared meaning. Until that translation happens, even the most significant breakthrough can be scientifically accepted while remaining culturally unresolved.
GLP-1 therapies offer a particularly visible example.

The science has advanced quickly. Our understanding of obesity has become more sophisticated, revealing the complex interplay of biology, hormones, metabolism, genetics, and environment. Our cultural understanding has evolved more slowly.

For generations, our culture has told a remarkably consistent story about weight. It is a story in which discipline triumphs over biology, effort reflects virtue, and our bodies become evidence of our character. Like all powerful cultural stories, it became almost invisible—not because everyone believed it, but because few of us stopped to question it.

Then biology changed.

New science doesn't erase old stories. It collides with them. Sometimes the collision is quiet. Sometimes it changes the way an entire society understands itself. GLP-1s did more than introduce a new treatment for obesity. They challenged not only a disease, but the explanation we had inherited for it.

That helps explain why the conversation has become so emotionally charged. People are not only asking whether these medicines work. They are asking what their existence means.

What do they mean for personal responsibility?

What do they mean for someone who has spent years believing their body reflected a failure of effort?

What do they mean for a society that has spent generations confusing biology with character?

These are not clinical questions. They are cultural ones. Which is precisely why they shape clinical behaviour.

We often assume that scientific innovation succeeds because the evidence is persuasive. Evidence is indispensable. But evidence alone cannot tell people how to fit a new scientific truth into an old understanding of themselves.

That requires translation. Not simplification. Translation.

Translation isn't about making science easier to understand. It is about helping society reconcile new scientific truths with old cultural ones. Communication helps people understand new information. Translation helps people reinterpret what that information means for their lives.

It is how new possibilities become new meanings. From what medicine makes possible into what people believe is possible for themselves.

GLP-1s do not enter culture as molecules. They enter as conversations between physicians and patients, questions around dinner tables, headlines, policy debates, moments of curiosity, and moments of judgment. This is how society begins to interpret a scientific possibility.

And interpretation matters because information and meaning do different things. Information tells us what is possible. Meaning tells us whether it is possible for us.

That is where permission begins.

We often think of permission as something granted by a physician, payer, or regulator.

Cultural permission works differently. It isn't granted. It emerges when people recognise themselves inside a new possibility.

Permission to ask about treatment.

To seek care without shame.

To see obesity as a chronic condition rather than a personal verdict.

To remain on therapy without feeling the need to defend it.

To imagine a different future.

Permission is not the same as awareness. Someone can know a treatment exists and still feel it is not meant for someone like them. They can understand the evidence and still fear what seeking care might say about their character. They can receive a prescription and still feel unable to fill it, discuss it, or continue taking it.

Awareness makes an option visible. Permission allows possibility to become behaviour. Healthcare has traditionally measured adoption through prescriptions, utilization, and adherence. Those measures tell us whether people are using a medicine. They do not always tell us whether society has made room for what that medicine represents.

A prescription records a clinical decision. Permission records a cultural one.
Lasting adoption depends on more than information alone. It diffuses through meaning.

We can see versions of this well beyond GLP-1s. New approaches to fertility care have required society to expand its understanding of how families begin. Advances in cancer have changed not only how we treat disease, but how we think about living with it. Progress in Alzheimer's disease is beginning to reshape our understanding of intervention, risk, and time.

The science differs. The cultural work is remarkably similar.

I've come to think this is the hidden work of every major scientific advancement. The science changes first. Society then has to decide what that change means.

Every meaningful innovation disrupts more than a treatment paradigm. It disrupts an inherited explanation. And replacing an inherited explanation requires more than better evidence.

A new scientific truth has to become a human truth.

Perhaps this is where healthcare marketing has an opportunity to contribute differently.

For decades, we have thought of our responsibility as communicating innovation. That responsibility remains. But it is no longer enough.

Our next responsibility is to help society make meaning of innovation. To understand not only what a breakthrough does, but what long-held beliefs it unsettles. To recognise the distance between what science now knows and what culture still believes. And ultimately, to help people find themselves inside what science has made possible.

To carry scientific possibility into the realities of everyday life without diminishing either the complexity of the science or the complexity of being human.

That requires more than messaging.

It requires listening before communicating.

Listening to the stories people already use to make sense of their health.

Understanding the identities those stories protect.

Recognizing when resistance is not a rejection of science, but a sign that meaning has yet to catch up.

And creating new meaning with people, rather than simply delivering information to them.

Every scientific breakthrough eventually becomes a question of meaning.

One day, GLP-1s will no longer feel culturally disruptive. They will simply become part of medicine. Not because every debate will disappear, but because society will have developed a new understanding of what they make possible.

The same will be true of discoveries we cannot yet imagine.

Science will continue to expand the boundaries of what is possible. That part is inevitable.

Whether those possibilities change people's lives depends on whether they become part of the stories we tell ourselves about what is possible.

Because innovation doesn't change the world the moment it is discovered.

It changes the world the moment people discover what it means for them.